Melek Yalcin Mutlu Jule Taubmann Jochen Wacker Koray Tascilar Filippo Fagni Maximilian Gerner Daniel Klett Georg Schett Bernhard Manger David Simon
10.3389/fmed.2022.934169
Front Med (Lausanne)
2022 Aug 3;9:934169.
covid-19 casirivimab/imdevimab immune mediated inflammatory disease neutralizing mabs rituximab systemic sclerosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/35991632/
Case Reports
PMC9381861
35991632
Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis-A case report and literature review
2022